Myocardial decompensation
|
2.9
|
1.1–7.2
| | | | |
Diabetes mellitus
| | |
2.7
|
1.3–5.5
|
2.0
|
1.3–3.0
|
Atrial fibrillation
| | |
2.3
|
1.1–5.2
|
2.8
|
1.8–4.4
|
Peripheral vascular disease
| | | | |
2.2
|
1.2–4.0
|
Antithrombine III (%)
|
0.97
|
0.94–0.99
|
0.96
|
0.94–0.99
| | |
Urea concentration (mg/dl)
| | |
1.02
|
1.01–1.03
|
1.02
|
1.011.02
|
Valve size
|
p = 0.009
| |
p = 0.05
| |
p = 0.02
| |
After Variable transformation:
| | | | | | |
Female and age > 74 years
|
4.0
|
1.4–11.0
| | | | |
BSA < 1.78 m2
| | |
3.0
|
1.51–6.07
| | |
Female and age > 80 years
| | | | |
1.8
|
1.03–2.94
|
BMI < 24 and body size < 165 cm
| | | | |
1.7
|
1.02–2.93
|
Valve size
|
p = 0.13
| |
p = 0.47
| |
p = 0.22
| |